SpaceX, Rackspace surge premarket; Edgewise Therapeutics, Huntsman fall
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St set for higher open as investors weigh Mideast negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Robinhood Markets (HOOD) PT Raised to $110 at Argus, 'Announces 10% headcount reduction; raising target'
June 17, 2026 7:16 AM EDTArgus analyst Stephen Biggar raised the price target on Robinhood Markets (NASDAQ: HOOD) to $110.00 (from $90.00) while maintaining a Buy rating.
The analyst comments "Announces 10% headcount reduction; raising target On June 16, the company said it would implement a workforce reduction involving 10% of its employees, which recently numbered 2,900, as it seeks a less heavily... More
Truist on SPX Technologies (SPXC): 'on track to achieve financial targets early'
June 16, 2026 3:43 PM EDTTruist Securities analyst Jamie Cook reiterated a Buy rating and $261.00 price target on SPX Technologies (NYSE: SPXC)
The analyst comments "Upside to revenue opportunity from capacity expansion: SPXC is investing to expand capacity for custom air handling and data center cooling products at both existing facilities (including Mirabel and Olathe) and new facilities (in Nashville, TN, and Madison, AL). Management is increasingly confident in the companys ability to drive more throughput, efficiency, and productivity at these facilities; recall last quarter SPXC noted these investments are expected to add ~$700M in incremental capacity by... More
Edgewise Therapeutics (EWTX) PT Raised to $52 at Leerink
June 16, 2026 1:08 PM EDTLeerink analyst Joseph Schwartz raised the price target on Edgewise Therapeutics (NASDAQ: EWTX) to $52.00 (from $50.00) while maintaining a Outperform rating.
The analyst comments "We continue to think that CIRRUS Part D checks the key boxes for EDG-7500 across obstructive (oHCM) and non-obstructive... More
